New York Professional Events List


European Due Diligence Summit for Life Sciences (EXL)


Date
Feb 26, 2018 - 08:00 AM - Feb 27, 05:00 PM
Organizer
New York Media Technologies LLC in association with EXL Events Inc
Location
Radisson Blu Portman Hotel, London22 Portman SquareLondonW1H 7BGUnited Kingdom,

United Kingdom,
United Kingdom,
US,
ZIP: United Kingdom
Phone:

Description

European Due Diligence Summit for Life Sciences

Recent years have shown a rise in development across the generic and biosimilar industries, as many blockbuster products near the end of their patents. The need to expand the reach of R&D programmes has driven major new investments in co-development, strategic alliances, licensing and acquisitions, with big pharmaceutical companies scrambling to maintain their strongholds in specific therapeutic areas. This has increased the need for a robust due diligence process across all functions, as companies look to external targets as a means of supplementing pipelines and bolstering their product portfolios.

With the rising costs of drug and device reviews and the uncertainty of FDA approvals, the prospect of developing a new product from discovery onward has become a highly risky endeavour. Therefore, conducting strategic due diligence to identify and integrate potential targets at a stage of assured success, though costly, can often be an efficient approach to supplement organic business development.

Over the last four years, ExL Events’ US-based conference has provided due diligence professionals with a platform to explore innovative models and deal structures for collaborating with strategic partners, and discussed valuable strategies for conducting efficient and effective due diligence. Join your peers at the inaugural European Due Diligence Summit for Life Sciences for the opportunity to network and engage with some of the industry’s leading experts.

Top Five Reasons to Attend

  1. Explore best practices for companies of all sizes looking to acquire or in-license a product
  2. Understand how to conduct a comprehensive intellectual property due diligence investigation, and how it can alter the strategy for your deal
  3. Learn how to evaluate and effectively manage strategic alliances through case studies from industry leaders
  4. Assess the regulatory and compliance standards of a target and how gaps can lead to unforeseen financial burdens
  5. Gain valuable insight on the impact company culture can have on the success of integrating the workforce post-merger or acquisition

Who Should Attend

This conference is designed for representatives from pharmaceutical, medical device and biotechnology companies with responsibilities in the following areas:

  • Due Diligence
  • Business Development
  • Strategic Alliance/Alliance Management
  • Mergers and Acquisitions
  • Licensing
  • Intellectual Property and Patent Counsel
  • Search and Evaluation
  • Portfolio Management
  • Scientific Assessment
  • General Counsel/Corporate Counsel
  • Legal and Regulatory Compliance
  • Regulatory Affairs
  • Research and Development
  • Clinical Medicine
  • Clinical Operations
  • Lifecycle Management

This conference is also of interest to:

  • Investment Banks
  • Private Equity Firms
  • Venture Capitalists
  • Data Room Providers
  • Due Diligence Consultants
  • Law Firms
  • Clinical Affairs and CRO Partners
  • Regulatory Affairs and Compliance Partners
 

Event Partners


MEDtube

MEDtube is an innovative video education platform for health professionals. It allows sharing videos and other materials with a community of more than 110,000 users worldwide, as well as building e-learning courses. The videoteque is updated daily and now contains almost 15,000 videos.

Website: http://MEDtube.net

PharmaLeaders

PharmaLeaders.com is an online environment dedicated to enriching the careers of more than 200,000 life sciences professionals. With breaking news and informative content grouped into one of nine segmented channels, in-depth special reports, job and events postings, and so much more, industry executives, manufacturers, marketers and educators can count on PharmaLeaders for the tools they need to succeed in today’s competitive market environment. For more information, visit us online at www.pharmaleaders.com, write to us at [email protected] or call 888-400-1573, ext. 240.

Website: http://pharmaleaders.com/

pharmaphorum.com

pharmaphorum drives innovation within the pharmaceutical industry, by bringing together healthcare through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.

Visit pharmaphorum today to share, discuss and debate: www.pharmaphorum.com

Website: http://www.pharmaphorum.com

PharmaVOICE

PharmaVOICE magazine, reaches more than 41,000 qualified subscribers and 100,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.

Website: http://www.pharmavoice.com

PM360

PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharma marketing professionals to succeed in the complex and highly regulated healthcare environment. The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including: planning and implementation of cutting edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the ‘360’ in our title signifies the combination of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read. By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.

Website: http://www.pm360online.com/

Technology Networks

Technology Networks is an internationally recognised publisher that provides access to the latest scientific news, products, research, videos and posters. Our global community is made up of over 300,000 researchers and scientific professionals from the life science, drug discover and analytical arenas.

Website: http://www.TechnologyNetworks.com



Agenda


AGENDA

--------
Day 1
--------

Monday, 26 February 2018
-----------------------------

8:00 – 8:45
Registration and Continental Breakfast

8:45 – 9:00
Chairperson’s Opening Remarks

Mike Myers, Senior Director, Lilly Research Labs — Due Diligence, ELI LILLY

9:00 – 9:45
Guidelines for Developing an Efficient and Targeted Due Diligence Plan

Chris Davie, Executive Director, Diligence, MUNDIPHARMA

9:45 – 10:30
Centre of Excellence: An Organisational Model for Driving Continuous Improvement in Due Diligence Practice

Gareth Ayre, Head Centre of Excellence, Due Diligence, NOVARTIS

10:30 – 11:00
Networking Break

11:00 – 11:45
Best Practice in Developing a Focused Intellectual Property Due Diligence Process

Steven Gurney, Principal Associate and Patent Attorney, MARKS & CLERK
Will James, Partner and Solicitor, MARKS & CLERK

11:45 – 12:30
Valuation Approaches for Licencing and M&A Transactions in the Life Science Industry

12:30 – 13:30
Luncheon

13:30 – 14:15
Identify Negotiation Factors That Can Impact the Purchase Price and Deal Structure of a Transaction

14:15 – 15:00
PANEL: Understand How to Make a Deal More Attractive to Investors

Lubor Gaal, Ph.D., Head of External Innovation and Licensing, ALMIRALL
Austin Doyle, Ph.D., FRSB, Director, Science and Technology Licensing, R&D Worldwide Business Development, GSK
Carl Jessop, FRQA, Due Diligence Director, Business Development, ASTRAZENECA

15:00 – 15:30
Networking Break

15:30 – 16:15
Partnerships, Prioritisation and Diligence

Nick Clarke, Ph.D., Head of U.K. Academic Partnerships, External Science and Innovation, PFIZER

16:15 – 17:00
Interactive Learning Discussion: Discover How Your Peers Conduct Due Diligence at Their Organisations

Mike Myers, Senior Director, Lilly Research Labs — Due Diligence, ELI LILLY

17:00 –
Day One Concludes

------------
Day 2
-----------

Tuesday, 27 February 2018
----------------------------------------

8:00 – 9:00
Continental Breakfast

9:00 – 9:15
Chairperson’s Recap of Day One

Mike Myers, Senior Director, Lilly Research Labs — Due Diligence, ELI LILLY

9:15 – 9:45
Successfully Run a Gap Analysis to Determine the Development Costs and Future Sales for an EarlyStage Asset

Marco Cerato, Head of BD&L, Late-Stage and Marketed Products, HELSINN

9:45 – 10:30
Case Study: Considerations for Selecting a Marketing or Promotion Partner That Is Right For Your Product

Roland Pfeiffer, Ph.D., Head Commercial Development Europe, VIFOR PHARMA

10:30 – 11:00
Networking Break

11:00 – 11:45
Virtual Due Diligence and How to Successfully Leverage Data Rooms

John Easton, Ph.D., Head of Business Operations, Business Development, ASTRAZENECA

11:45 – 12:30
Panel: Effective Strategies for Working With External Advisors and Consultants

Cristiano Musso, Chief Business Officer, CIRCASSIA

12:30 – 13:15
Luncheon

13:15 – 14:00
Integration Management: The Challenge of Avoiding Value Deprivation of a Deal Post-Due Diligence

Robert Bauer, Ph.D., Director, Business Development EMEA, SANTEN

14:00 – 14:45
Case Study: Recognising and Challenging Bias in Navigating Portfolio Decision-Making

Mike Myers, Senior Director, Lilly Research Labs — Due Diligence, ELI LILLY

14:45 – 15:00
Chairperson’s Closing Remarks

15:00 –
Conference Concludes



Speaker Details


CONFERENCE CHAIRPERSON


Mike Myers,
Senior Director, Lilly Research Labs — Due Diligence,
ELI LILLY

SPEAKERS


Gareth Ayre,
Head Centre of Excellence, Due Diligence,




NOVARTIS
Cristiano Musso,
Chief Business Officer,

Roland Pfeiffer, Ph.D.,
CIRCASSIA
Head, Commercial Development Europe,

Chris Davie,
VIFOR PHARMA
Executive Director, Diligence,

Lubor Gaal,
MUNDIPHARMA
Head, External Innovation and Licensing,
ALMIRALL

Please contact the event manager Marilyn below for the following: 
- Discounts for registering 5 or more participants.
- If you company requires a price quotation.
Event Manager Contact: marilyn.b.turner(at)nyeventslist.com
You can also contact us if you require a visa invitation letter, after ticket purchase. 
We can also provide a certificate of completion for this event if required.

NO REFUNDS ALLOWED ON REGISTRATIONS 
-----------------------------------------------------------------
This Event Listing is Promoted by
New York Media Technologies LLC in association
with EXL Events Inc
http://www.NyEventsList.com
http://www.BostonEventsList.com
http://www.SFBayEventsList.com
-----------------------------------------------------------------
MYL170915CEV MAR170926UPT SAN171106UPT

 

Event Categories
Life Sciences, Biotechnology
,
SCIENCE AND TECHNOLOGY CONFERENCES
,
Technology
Keywords: fun, access , assessment , audience, business , Clinical , community , conference , culture, design




Comments








Events Calendar

SunMonTueWedThuFriSat
28 29 30 31 1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 1 2 3

Event Location

Newsletters

Subscribe
VIP Life Time Subscription to our Newsletters!
$399.99
$299.99